| Kathryn Rosa Schott, MD | |
|
2202 N John B Dennis Hwy Ste 200, Kingsport, TN 37660-5918 | |
| (423) 232-6120 | |
| (423) 232-6125 |
| Full Name | Kathryn Rosa Schott |
|---|---|
| Gender | Female |
| Speciality | Pain Management |
| Experience | 9 Years |
| Location | 2202 N John B Dennis Hwy Ste 200, Kingsport, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083001283 | NPI | - | NPPES |
| Q059366 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 209856 (North Carolina) | Secondary |
| 208VP0014X | Pain Medicine - Interventional Pain Medicine | 61498 (Tennessee) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pain Consultants Of East Tennessee, Pllc | 3173424298 | 16 |
News Archive
Montefiore Health System (Montefiore) and Yeshiva University (Yeshiva) announced today that they have finalized a new agreement for Albert Einstein College of Medicine (Einstein), where Montefiore assumes operational authority and responsibility for Einstein, while Yeshiva remains responsible for academic oversight, including the granting of degrees.
In the course of a study conducted throughout Germany, medical professionals have compared different treatment methods for Neuromyelitis optica, an inflammatory disease of the central nervous system. It turned out that the best results were not achieved with conventional steroid therapy.
Allopurinol, a relatively inexpensive anti-gout medication that has been on the market for more than 20 years, may have some activity against colorectal adenomas, according to data presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held here Nov. 7-10, 2010.
Though H1N1 (swine flu) activity worldwide has slowed, the potential of a new wave of infections in the northern hemisphere in late winter or early spring remains viable, Keiji Fukuda, the WHO's top flu expert, said Monday at the start of the WHO's weeklong executive board meeting, Reuters reports.
Microbix Biosystems Inc., a biotechnology company commercializing novel technologies for influenza vaccine manufacturing and livestock semen sexing, in addition to a core business of virology products, today reported financial results for the first quarter of fiscal 2011. For the quarter ended December 31, 2010, Microbix reported revenues of $812,694, a 34% decrease from $1,226,538 for the same period in 2009.
› Verified 3 days ago
| Entity Name | Pain Consultants Of East Tennessee, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609890383 PECOS PAC ID: 3173424298 Enrollment ID: O20040120000674 |
News Archive
Montefiore Health System (Montefiore) and Yeshiva University (Yeshiva) announced today that they have finalized a new agreement for Albert Einstein College of Medicine (Einstein), where Montefiore assumes operational authority and responsibility for Einstein, while Yeshiva remains responsible for academic oversight, including the granting of degrees.
In the course of a study conducted throughout Germany, medical professionals have compared different treatment methods for Neuromyelitis optica, an inflammatory disease of the central nervous system. It turned out that the best results were not achieved with conventional steroid therapy.
Allopurinol, a relatively inexpensive anti-gout medication that has been on the market for more than 20 years, may have some activity against colorectal adenomas, according to data presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held here Nov. 7-10, 2010.
Though H1N1 (swine flu) activity worldwide has slowed, the potential of a new wave of infections in the northern hemisphere in late winter or early spring remains viable, Keiji Fukuda, the WHO's top flu expert, said Monday at the start of the WHO's weeklong executive board meeting, Reuters reports.
Microbix Biosystems Inc., a biotechnology company commercializing novel technologies for influenza vaccine manufacturing and livestock semen sexing, in addition to a core business of virology products, today reported financial results for the first quarter of fiscal 2011. For the quarter ended December 31, 2010, Microbix reported revenues of $812,694, a 34% decrease from $1,226,538 for the same period in 2009.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kathryn Rosa Schott, MD 2202 N John B Dennis Hwy Ste 200, Kingsport, TN 37660-5918 Ph: (423) 392-6690 | Kathryn Rosa Schott, MD 2202 N John B Dennis Hwy Ste 200, Kingsport, TN 37660-5918 Ph: (423) 232-6120 |
News Archive
Montefiore Health System (Montefiore) and Yeshiva University (Yeshiva) announced today that they have finalized a new agreement for Albert Einstein College of Medicine (Einstein), where Montefiore assumes operational authority and responsibility for Einstein, while Yeshiva remains responsible for academic oversight, including the granting of degrees.
In the course of a study conducted throughout Germany, medical professionals have compared different treatment methods for Neuromyelitis optica, an inflammatory disease of the central nervous system. It turned out that the best results were not achieved with conventional steroid therapy.
Allopurinol, a relatively inexpensive anti-gout medication that has been on the market for more than 20 years, may have some activity against colorectal adenomas, according to data presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held here Nov. 7-10, 2010.
Though H1N1 (swine flu) activity worldwide has slowed, the potential of a new wave of infections in the northern hemisphere in late winter or early spring remains viable, Keiji Fukuda, the WHO's top flu expert, said Monday at the start of the WHO's weeklong executive board meeting, Reuters reports.
Microbix Biosystems Inc., a biotechnology company commercializing novel technologies for influenza vaccine manufacturing and livestock semen sexing, in addition to a core business of virology products, today reported financial results for the first quarter of fiscal 2011. For the quarter ended December 31, 2010, Microbix reported revenues of $812,694, a 34% decrease from $1,226,538 for the same period in 2009.
› Verified 3 days ago